AR041955A1 - Procedimiento para la preparacion de compuestos de imidazolilo - Google Patents

Procedimiento para la preparacion de compuestos de imidazolilo

Info

Publication number
AR041955A1
AR041955A1 ARP030104180A ARP030104180A AR041955A1 AR 041955 A1 AR041955 A1 AR 041955A1 AR P030104180 A ARP030104180 A AR P030104180A AR P030104180 A ARP030104180 A AR P030104180A AR 041955 A1 AR041955 A1 AR 041955A1
Authority
AR
Argentina
Prior art keywords
hydrogen
alkyl
preparation
compound
optionally substituted
Prior art date
Application number
ARP030104180A
Other languages
English (en)
Inventor
Jan-Maarten Verbeek
Der Meij Paulus F C Van
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of AR041955A1 publication Critical patent/AR041955A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente se refiere a un método para la preparación de un compuestos de imidazolilo de la fórmula general (1), en donde: Ra y Rb cada uno separadamente son alquilo (C1-6), alcoxialquilo (C1-6), arilo o heteroarilo opcionalmente sustituidos; o en donde Ra y Rb juntos forman un sistema homocíclico o heterocíclico adicional que comprende uno o más anillos; Ra' y Rb' son cada uno hidrógeno o juntos forman un doble enlace carbono-carbono, siendo dicho doble enlace carbono-carbono opcionalmente parte de un sistema aromático; Rc es hidrógeno, alquilo (C1-6), alcoxi (C-16), alcoxialquilo (C1-6) o halógeno; Rd es hidrógeno o alquilo (C1-4); Re es hidrógeno o alquilo (C1-4); m es 1 ó 2; y R1 es hidrógeno o alquilo (C1-4); así como sus sales de adición de ácido; caracterizado porque se hace reaccionar un compuesto de la fórmula general (2), con un compuesto de la fórmula (3), en donde: R es hidrógeno, un grupo alquilo (C1-4) opcionalmente sustituido con un grupo alcoxi o un grupo arilo opcionalmente sustituido, R', R'', R''', R'''' cada uno individualmente son un hidrógeno o un grupo alquilo (C1-4), seguido por la reacción con un compuesto de la fórmula (4), en donde R1, Rd y Re tienen los significados definidos precedentemente; y opcionalmente seguido por la reacción con un ácido adecuado. El método de acuerdo con la presente es especialmente útil para la preparación de ondansetrón y cilansetrón
ARP030104180A 2002-11-18 2003-11-13 Procedimiento para la preparacion de compuestos de imidazolilo AR041955A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02079838 2002-11-18

Publications (1)

Publication Number Publication Date
AR041955A1 true AR041955A1 (es) 2005-06-01

Family

ID=32319633

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030104180A AR041955A1 (es) 2002-11-18 2003-11-13 Procedimiento para la preparacion de compuestos de imidazolilo

Country Status (25)

Country Link
EP (1) EP1565445B1 (es)
JP (1) JP4611026B2 (es)
KR (1) KR20050075026A (es)
CN (1) CN100349873C (es)
AR (1) AR041955A1 (es)
AT (1) ATE340783T1 (es)
AU (1) AU2003296762B2 (es)
BR (1) BR0316308A (es)
CA (1) CA2504614C (es)
DE (1) DE60308720T2 (es)
DK (1) DK1565445T3 (es)
ES (1) ES2273088T3 (es)
HK (1) HK1081188A1 (es)
HR (1) HRP20050376A2 (es)
IL (1) IL168258A (es)
MX (1) MXPA05005261A (es)
NO (1) NO330342B1 (es)
PL (1) PL376743A1 (es)
PT (1) PT1565445E (es)
RU (1) RU2314296C2 (es)
SA (1) SA03240414B1 (es)
SI (1) SI1565445T1 (es)
UA (1) UA79655C2 (es)
WO (1) WO2004046116A1 (es)
ZA (1) ZA200503425B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2059491T3 (es) * 1987-06-29 1994-11-16 Duphar Int Res Derivados de indol con anillos condensados.

Also Published As

Publication number Publication date
CA2504614C (en) 2010-09-28
RU2314296C2 (ru) 2008-01-10
RU2005119155A (ru) 2006-01-20
HK1081188A1 (en) 2006-05-12
SI1565445T1 (sl) 2007-02-28
DK1565445T3 (da) 2007-01-29
AU2003296762B2 (en) 2010-03-18
HRP20050376A2 (en) 2006-02-28
DE60308720T2 (de) 2007-01-11
EP1565445A1 (en) 2005-08-24
DE60308720D1 (de) 2006-11-09
MXPA05005261A (es) 2005-07-25
KR20050075026A (ko) 2005-07-19
CA2504614A1 (en) 2004-06-03
NO330342B1 (no) 2011-03-28
EP1565445B1 (en) 2006-09-27
WO2004046116A1 (en) 2004-06-03
BR0316308A (pt) 2005-09-27
CN1714082A (zh) 2005-12-28
SA03240414B1 (ar) 2006-12-05
IL168258A (en) 2010-05-31
ES2273088T3 (es) 2007-05-01
JP4611026B2 (ja) 2011-01-12
UA79655C2 (en) 2007-07-10
JP2006512322A (ja) 2006-04-13
NO20052950L (no) 2005-08-15
PT1565445E (pt) 2007-01-31
AU2003296762A1 (en) 2004-06-15
CN100349873C (zh) 2007-11-21
NO20052950D0 (no) 2005-06-16
ATE340783T1 (de) 2006-10-15
ZA200503425B (en) 2007-02-28
PL376743A1 (pl) 2006-01-09

Similar Documents

Publication Publication Date Title
AR060489A1 (es) Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol
AR067413A1 (es) Compuestos heterociclicos que contienen ciclopenta[d]pirimidina inhibidores de proteinquinasas akt, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de las mismas para el tratamiento de enfermedades hiperproliferativas, tales como cancer
AR083213A1 (es) Proceso de preparacion de derivados pirimidinicos, compuestos intermediarios y proceso para prepararlos
EA201170096A1 (ru) Замещенные производные пиримидона
AR070130A1 (es) Compuestos moduladores de beta-amiloide, un proceso para su obtencion, el uso del compuesto para la fabricacion de un medicamento y dicho medicamento
AR047531A1 (es) Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa
AR073136A1 (es) Compuestos de pirrol
EA200701470A1 (ru) Способы получения производных 4-(фенокси-5-метилпиримидин-4-илокси)пиперидин-1-карбоновой кислоты и родственных соединений
AR087683A1 (es) N-[1-((6-cloropiridin-3-il)metil)piridin-2-(1h)-ilideno]-2,2,2-trifluoroacetamida, metodo para su preparacion y un intermediario para su sintesis
EA201170237A1 (ru) Производные карбаматов алкилтиазолов, их получение и их применение в терапии
DK2197860T3 (da) Nye forbindelser som adenosin-A1-receptorantagonister
AR089221A1 (es) Disales de acido malonico y metodo para preparar diahaluros de malonilo
EA201171385A1 (ru) Производные циклопента[с]пирролилалкилкарбаматов 5-членных гетероциклов, способ их получения и применение их в терапии
AR075531A1 (es) Derivados de piperazin-ciclopropil benzamidas, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de trastornos del sistema nervioso central, tales como alzheimer y esquizofrenia, entre otros
AR087771A1 (es) Moduladores de la pde10
Nakata et al. (R)-(+)-N-Methylbenzoguanidine ((R)-NMBG) catalyzed kinetic resolution of racemic secondary benzylic alcohols with free carboxylic acids by asymmetric esterification
DOP2012000296A (es) Derivados de 3,4-dihidropirrolo[1,2-a]pirazina-2,8(1h)-dicarboxamida su preparación y su uso terapéutico
AR041955A1 (es) Procedimiento para la preparacion de compuestos de imidazolilo
DOP2011000296A (es) Compuesto de pirazol
BR112012012378A2 (pt) método para fabricar um composto, e, composto
MX2022002362A (es) Derivado de 2-aminoquinazolinona.
AR075441A1 (es) Un proceso para la preparacion de etoricoxib
AR046106A1 (es) Derivados de 2-(4-sulfonilamino) -3-hidroxi-3,4-dihidro-2h-cromen-6-ilosustituidos con amidometilo procedimiento y productos intermedios para su preparacion y medicamentos que contienen a estos compuestos
EA200800633A1 (ru) Способ получения производных сартана и промежуточных соединений, пригодных для этого способа
ES2561879T3 (es) Derivados de piridilbenzoxazina, composición farmacéutica que comprende los mismos y uso de los mismos

Legal Events

Date Code Title Description
FB Suspension of granting procedure